Upgrade to SI Premium - Free Trial

Erasca, Inc (ERAS)

19.43 +0.05 (0.26%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 144 Erasca, Inc. Filed by: Erasca Foundation July 21, 2026 4:05 PM - SEC Filing Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Photronics, Inc. (NASDAQ: PLAB); and Via Transportation, Inc. (NYSE: VIA): Grabar Law Office is Inv July 21, 2026 8:44 AM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline July 20, 2026 3:46 PM - StreetInsider Erasca Inc (ERAS) PT Raised to $21 at Morgan Stanley July 20, 2026 8:43 AM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline July 17, 2026 4:09 PM - StreetInsider Erasca closes $632.5M public offering of common stock July 15, 2026 4:02 PM - StreetInsider Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares July 15, 2026 4:01 PM - Globe NewsWire Form 8-K Erasca, Inc. For: Jul 13 July 14, 2026 5:03 PM - SEC Filing Form 424B5 Erasca, Inc. July 14, 2026 5:01 PM - SEC Filing Erasca Inc (ERAS) PT Raised to $24 at Jefferies, 'underappreciated' July 14, 2026 3:53 PM - StreetInsider Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O July 14, 2026 10:27 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Erasca Inc (ERAS) July 14, 2026 6:59 AM - StreetInsider Erasca prices upsized stock offering at $17.50 per share July 13, 2026 11:10 PM - StreetInsider Erasca Announces Pricing of Upsized Public Offering of Common Stock July 13, 2026 11:10 PM - Globe NewsWire Form 424B5 Erasca, Inc. July 13, 2026 5:24 PM - SEC Filing Form 8-K Erasca, Inc. For: Jul 13 July 13, 2026 4:19 PM - SEC Filing Erasca proposes $500M common stock public offering July 13, 2026 4:19 PM - StreetInsider Erasca Announces Proposed Public Offering of $500 Million of Common Stock July 13, 2026 4:19 PM - Globe NewsWire Erasca, Inc (ERAS) files mixed shelf July 13, 2026 4:18 PM - StreetInsider Form S-3ASR Erasca, Inc. July 13, 2026 4:16 PM - SEC Filing Erasca reports Phase 1 data for ERAS-0015 in KRAS-mutant tumors July 13, 2026 4:01 PM - StreetInsider Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors July 13, 2026 4:01 PM - Globe NewsWire Goldman Sachs Starts Erasca Inc (ERAS) at Early-Stage Biotech July 13, 2026 5:09 AM - StreetInsider Attention Long-Term Shareholders of Embecta Corp. (NSADAQ: EMBC); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and ZoomInfo Technologies, Inc. (NASDAQ: GTM): Grabar Law Office is Inves July 10, 2026 9:06 AM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline July 8, 2026 10:15 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline July 7, 2026 3:05 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline July 6, 2026 1:33 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline July 2, 2026 5:44 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline July 1, 2026 5:42 PM - StreetInsider Form 8-K Erasca, Inc. For: Jun 26 July 1, 2026 6:01 AM - SEC Filing Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 30, 2026 4:08 PM - StreetInsider Form 4 Erasca, Inc. For: Jun 26 Filed by: Start Valerie Denise Harding June 29, 2026 7:08 PM - SEC Filing Form 4 Erasca, Inc. For: Jun 26 Filed by: LIU JEAN I June 29, 2026 7:07 PM - SEC Filing Form 4 Erasca, Inc. For: Jun 26 Filed by: Multani Pratik S June 29, 2026 7:05 PM - SEC Filing Form 4 Erasca, Inc. For: Jun 26 Filed by: Casdin Alexander W. June 29, 2026 7:05 PM - SEC Filing Form 4 Erasca, Inc. For: Jun 26 Filed by: Bristol James Arthur June 29, 2026 7:03 PM - SEC Filing Form 4 Erasca, Inc. For: Jun 26 Filed by: Hambleton Julie June 29, 2026 7:03 PM - SEC Filing Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 29, 2026 4:06 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 25, 2026 3:47 PM - StreetInsider INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Erasca, Inc. (ERAS) to Contact Law Firm June 25, 2026 1:47 PM - Globe NewsWire Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 24, 2026 3:45 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 23, 2026 3:36 PM - StreetInsider Lost Money on Erasca, Inc. (ERAS)? Join Class Action Suit Seeking Recovery - Contact SueWallSt June 23, 2026 10:09 AM - Globe NewsWire Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Embecta Corp. (NASDAQ: EMBC); Navan, Inc. (NASDAQ: NAVN); and Power Solutions International, I June 23, 2026 8:16 AM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 22, 2026 2:01 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 19, 2026 4:39 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 18, 2026 4:38 PM - StreetInsider Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline June 17, 2026 4:33 PM - StreetInsider Form 144 Erasca, Inc. Filed by: Erasca Foundation June 15, 2026 5:53 PM - SEC Filing BofA Securities Upgrades Erasca Inc (ERAS) to Neutral, 'we see the downside case as now less compelling' June 4, 2026 5:12 AM - StreetInsider Erasca to Present at the Jefferies Global Healthcare Conference May 27, 2026 8:00 AM - Globe NewsWire Form 144 Erasca, Inc. Filed by: Erasca Foundation May 15, 2026 4:47 PM - SEC Filing Form SCHEDULE 13G/A Erasca, Inc. Filed by: Venrock Healthcare Capital Partners III, L.P. May 15, 2026 4:41 PM - SEC Filing Form SCHEDULE 13G/A Erasca, Inc. Filed by: Paradigm Biocapital Advisors LP May 15, 2026 4:32 PM - SEC Filing Form SCHEDULE 13G/A Erasca, Inc. Filed by: T. Rowe Price Investment Management, Inc. May 15, 2026 10:07 AM - SEC Filing Form SCHEDULE 13G Erasca, Inc. Filed by: RTW INVESTMENTS, LP May 15, 2026 8:21 AM - SEC Filing Form SCHEDULE 13G/A Erasca, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC May 12, 2026 6:25 PM - SEC Filing Erasca Inc (ERAS) PT Lowered to $26 at Mizuho May 12, 2026 5:04 AM - StreetInsider Erasca, Inc. (ERAS) Misses Q1 EPS by 49c May 11, 2026 4:31 PM - StreetInsider Form 10-Q Erasca, Inc. For: Mar 31 May 11, 2026 4:14 PM - SEC Filing Form 8-K Erasca, Inc. For: May 11 May 11, 2026 4:06 PM - SEC Filing Erasca Reports First Quarter 2026 Business Updates and Financial Results May 11, 2026 4:01 PM - Globe NewsWire Erasca partners with Merck for cancer drug combination trial May 11, 2026 7:00 AM - StreetInsider Erasca partners with Merck for cancer drug combination trial May 11, 2026 7:00 AM - StreetInsider Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) May 11, 2026 7:00 AM - Globe NewsWire Erasca to Present at the Bank of America Securities Health Care Conference May 6, 2026 8:00 AM - Globe NewsWire SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton May 1, 2026 4:09 PM - StreetInsider Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses April 29, 2026 12:23 PM - StreetInsider Form ARS Erasca, Inc. For: Dec 31 April 28, 2026 4:50 PM - SEC Filing Form DEFA14A Erasca, Inc. April 28, 2026 4:43 PM - SEC Filing Form DEF 14A Erasca, Inc. For: Jun 26 April 28, 2026 4:41 PM - SEC Filing Erasca shares cut in half after patient death in clinical trial April 28, 2026 1:54 PM - StreetInsider Increasing unusual option volume: ERAS SANM OGN BBBY SNBR PAGS CDNS PII April 28, 2026 10:49 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Erasca Inc (ERAS) April 28, 2026 6:42 AM - StreetInsider Erasca Inc (ERAS) PT Raised to $9 at BofA Securities April 28, 2026 5:14 AM - StreetInsider Erasca, Inc (ERAS) releases slides on phase 1 data for RAS cancer drug ERAS-0015 April 27, 2026 4:49 PM - StreetInsider Form 8-K Erasca, Inc. For: Apr 27 April 27, 2026 4:18 PM - SEC Filing Erasca reports positive early data for cancer drug ERAS-0015 April 27, 2026 4:01 PM - StreetInsider Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors April 27, 2026 4:01 PM - Globe NewsWire Form 8-K Erasca, Inc. For: Apr 27 April 27, 2026 8:31 AM - SEC Filing Erasca to discuss phase 1 data for RAS cancer drug ERAS-0015 April 27, 2026 8:30 AM - StreetInsider Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 April 27, 2026 8:30 AM - Globe NewsWire Erasca Inc (ERAS) PT Raised to $30 at Stifel After CEO Chat April 27, 2026 6:05 AM - StreetInsider Erasca Inc (ERAS) PT Raised to $28 at Mizuho April 27, 2026 3:56 AM - StreetInsider Full Article List